here is the link to the financials
looks to pretty much in line with increases associated with phase II which is natural.
cash flow to cover 5-6 months of burn. will probably need financing or some sort of partnership early summer next year but would be expected. the farther you progress into clinical phases, the cost rises.
hopefully regional deal becomes know